{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:24:13Z","timestamp":1789932253808,"version":"4.0.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is a major neurodegenerative disease for which there is currently no curative treatment. The blood-brain barrier (BBB), multiple physiological functions formed by mainly specialized brain microvascular endothelial cells (BMECs), serves as a gatekeeper to protect the central nervous system (CNS) from harmful molecules in the blood and aberrant immune cell infiltration. The accumulation of evidence indicating that alterations in the peripheral milieu can contribute to neurodegeneration within the CNS suggests that the BBB may be a previously overlooked factor in the pathogenesis of ALS. Animal models suggest BBB breakdown may precede neurodegeneration and link BBB alteration to the disease progression or even onset. However, the lack of a useful patient-derived model hampers understanding the pathomechanisms of BBB dysfunction and the development of BBB-targeted therapies. In this study, we differentiated BMEC-like cells from human induced pluripotent stem cells (hiPSCs) derived from ALS patients to investigate BMEC functions in ALS patients. <jats:italic>TARDBP<\/jats:italic><jats:sup>N345K\/+<\/jats:sup> carrying patient-derived BMEC-like cells exhibited increased permeability to small molecules due to loss of tight junction in the absence of neurodegeneration or neuroinflammation, highlighting that BMEC abnormalities in ALS are not merely secondary consequences of disease progression. Furthermore, they exhibited increased expression of cell surface adhesion molecules like ICAM-1 and VCAM-1, leading to enhanced immune cell adhesion. BMEC-like cells derived from hiPSCs with other types of <jats:italic>TARDBP<\/jats:italic> gene mutations (<jats:italic>TARDBP<\/jats:italic><jats:sup>K263E\/K263E<\/jats:sup> and <jats:italic>TARDBP<\/jats:italic><jats:sup>G295S\/G295S<\/jats:sup>) introduced by genome editing technology did not show such BMEC dysfunction compared to the isogenic control. Interestingly, transactive response DNA-binding protein 43 (TDP-43) was mislocalized to cytoplasm in <jats:italic>TARDBP<\/jats:italic><jats:sup>N345K\/+<\/jats:sup> carrying model. Wnt\/\u03b2-catenin signaling was downregulated in the ALS patient (<jats:italic>TARDBP<\/jats:italic><jats:sup>N345K\/+<\/jats:sup>)-derived BMEC-like cells and its activation rescued the leaky barrier phenotype and settled down VCAM-1 expressions. These results indicate that <jats:italic>TARDBP<\/jats:italic><jats:sup>N345K\/+<\/jats:sup> carrying model recapitulated BMEC abnormalities reported in brain samples of ALS patients. This novel patient-derived BMEC-like cell is useful for the further analysis of the involvement of vascular barrier dysfunctions in the pathogenesis of ALS and for promoting therapeutic drug discovery targeting BMEC.<\/jats:p>","DOI":"10.3389\/fcell.2024.1357204","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:35:50Z","timestamp":1723696550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Establishment of a novel amyotrophic lateral sclerosis patient (TARDBPN345K\/+)-derived brain microvascular endothelial cell model reveals defective Wnt\/\u03b2-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction"],"prefix":"10.3389","volume":"12","author":[{"given":"Kinya","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nagamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusei","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1212\/wnl.57.7.1282","article-title":"Immune reactivity in a mouse model of familial ALS correlates with disease progression","volume":"57","author":"Alexianu","year":"2001","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e177819","DOI":"10.1172\/jci.insight.177819","article-title":"Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation","volume":"9","author":"Arribas","year":"2024","journal-title":"JCI Insight"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.13.571184","article-title":"Loss of endothelial TDP-43 leads to blood brain barrier defects in mouse models of amyotrophic lateral sclerosis and frontotemporal dementia","author":"Cheemala","year":"2023"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e74065","DOI":"10.7554\/eLife.74065","article-title":"Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis","volume":"11","author":"Cui","year":"2022","journal-title":"Elife"},{"key":"B5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1073\/pnas.0805165106","article-title":"Wnt\/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis","volume":"106","author":"Daneman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood-brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","article-title":"Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis","volume":"50","author":"Engelhardt","year":"1993","journal-title":"Archives Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/jnen\/nlaa162","article-title":"TDP-43 vasculopathy in the spinal cord in sporadic amyotrophic lateral sclerosis (sALS) and frontal cortex in sALS\/FTLD-TDP","volume":"80","author":"Ferrer","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/imcb.12674","article-title":"Activators of neurotoxic microglia in neurodegeneration: is the answer in blood?","volume":"101","author":"Finney","year":"2023","journal-title":"Immunol. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00415-014-7575-5","article-title":"Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations","volume":"262","author":"Floris","year":"2015","journal-title":"J. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2022.06.004","article-title":"Blocking immune cell infiltration of the central nervous system to tame Neuroinflammation in Amyotrophic lateral sclerosis","volume":"105","author":"Garofalo","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","article-title":"Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis","volume":"11","author":"Garofalo","year":"2020","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70992","article-title":"Wnt signaling mediates acquisition of blood-brain barrier properties in na\u00efve endothelium derived from human pluripotent stem cells","author":"Gastfriend","year":""},{"key":"B17","doi-asserted-by":"publisher","first-page":"e70992","DOI":"10.7554\/eLife.70992","article-title":"Wnt signaling mediates acquisition of blood\u2013brain barrier properties in na\u00efve endothelium derived from human pluripotent stem cells","volume":"10","author":"Gastfriend","year":"","journal-title":"eLife"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/acn3.51853","article-title":"The role of peripheral immunity in ALS: a population-based study","volume":"10","author":"Grassano","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14660820410020286","article-title":"Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells","volume":"5","author":"Graves","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40142-020-00194-8","article-title":"Genetics of amyotrophic lateral sclerosis","volume":"8","author":"Gregory","year":"2020","journal-title":"Curr. Genet. Med. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","article-title":"Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue","volume":"55","author":"Henkel","year":"2004","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1169962","DOI":"10.3389\/fcell.2023.1169962","article-title":"Loss of TDP-43 causes ectopic endothelial sprouting and migration defects through increased fibronectin, vcam 1 and integrin \u03b14\/\u03b21","volume":"11","author":"Hipke","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"ENEURO.0061","DOI":"10.1523\/ENEURO.0061-22.2022","article-title":"Pathogenic mutation of TDP-43 impairs RNA processing in a cell type-specific manner: implications for the pathogenesis of ALS\/FTLD","volume":"9","author":"Imaizumi","year":"2022","journal-title":"eNeuro"},{"key":"B24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12974-019-1589-y","article-title":"MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology","volume":"16","author":"Jara","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12987-019-0139-4","article-title":"The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model","volume":"16","author":"Katt","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"B27","first-page":"691","article-title":"Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue","volume":"140","author":"Kawamata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.1073\/pnas.1614336114","article-title":"Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis","volume":"114","author":"Lecuyer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.scr.2020.101896","article-title":"Generation of an ALS human iPSC line KEIOi001-A from peripheral blood of a Charcot disease-affected patient carrying TARDBP p.N345K heterozygous SNP mutation","volume":"47","author":"Leventoux","year":"2020","journal-title":"Stem Cell Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00401-024-02734-w","article-title":"Aberrant CHCHD2-associated mitochondriopathy in Kii ALS\/PDC astrocytes","volume":"147","author":"Leventoux","year":"2024","journal-title":"Acta Neuropathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","article-title":"TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD","volume":"349","author":"Ling","year":"2015","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/srep04160","article-title":"A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources","volume":"4","author":"Lippmann","year":"2014","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamaneurol.2016.6179","article-title":"Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis","volume":"74","author":"Lunetta","year":"2017","journal-title":"JAMA Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vasc. Biol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3791\/65134","article-title":"Differentiation of human induced pluripotent stem cells to brain microvascular endothelial cell-like cells with a mature immune phenotype","volume":"195","author":"Matsuo","year":"2023","journal-title":"J. Vis. Exp."},{"key":"B36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jnr.22594","article-title":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"89","author":"Miyazaki","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery","volume":"30","author":"Morimoto","year":"2023","journal-title":"Cell Stem Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","article-title":"Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression","volume":"74","author":"Murdock","year":"2017","journal-title":"JAMA Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","article-title":"Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat","volume":"1301","author":"Nicaise","year":"2009","journal-title":"Brain Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"100563","DOI":"10.1016\/j.xpro.2021.100563","article-title":"Differentiation of human pluripotent stem cells to brain microvascular endothelial cell-like cells suitable to study immune cell interactions","volume":"2","author":"Nishihara","year":"2021","journal-title":"Star. Protoc."},{"key":"B42","doi-asserted-by":"publisher","first-page":"16693","DOI":"10.1096\/fj.202001507RR","article-title":"Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions","volume":"34","author":"Nishihara","year":"2020","journal-title":"FASEB J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1093\/brain\/awac019","article-title":"Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis","volume":"145","author":"Nishihara","year":"2022","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/jnc.16005","article-title":"Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis","volume":"167","author":"Okano","year":"2023","journal-title":"J. Neurochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tips.2019.12.002","article-title":"Ropinirole, a new ALS drug candidate developed using iPSCs","volume":"41","author":"Okano","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.13.571178","article-title":"Targeted inCITE-seq analysis identifies the loss of nuclear TDP-43 in endothelium as a mediator of blood brain barrier signaling pathway dysfunction in neurodegeneration","author":"Omar","year":"2023"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1000193","DOI":"10.1371\/journal.pgen.1000193","article-title":"Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis","volume":"4","author":"Rutherford","year":"2008","journal-title":"PLoS Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","article-title":"Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration","volume":"19","author":"Ryu","year":"2018","journal-title":"Nat. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e36187","DOI":"10.7554\/eLife.36187","article-title":"Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells","volume":"7","author":"Sabbagh","year":"2018","journal-title":"Elife"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2015.05.005","article-title":"Alterations in the blood-spinal cord barrier in TDP-43 conditional knockout mice","volume":"598","author":"Sasaki","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B52","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/biom11040562","article-title":"Role of thrombin in central nervous system injury and disease","volume":"11","author":"Shlobin","year":"2021","journal-title":"Biomolecules"},{"key":"B53","doi-asserted-by":"publisher","first-page":"12358","DOI":"10.1038\/s41598-020-69096-7","article-title":"Transcriptomic comparison of human and mouse brain microvessels","volume":"10","author":"Song","year":"2020","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/science.1164594","article-title":"Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature","volume":"322","author":"Stenman","year":"2008","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/neup.12559","article-title":"p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: an autopsy case","volume":"39","author":"Takeda","year":"2019","journal-title":"Neuropathology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s42003-024-05925-z","article-title":"Generation of human iPSC-derived phrenic-like motor neurons to model respiratory motor neuron degeneration in ALS","volume":"7","author":"Thiry","year":"2024","journal-title":"Commun. Biol."},{"key":"B58","first-page":"289","article-title":"Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis","volume":"8","author":"Troost","year":"1989","journal-title":"Clin. Neuropathol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2990.1990.tb01276.x","article-title":"Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis","volume":"16","author":"Troost","year":"1990","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J. Neurochem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1021\/acs.molpharmaceut.0c00178","article-title":"Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and the blood-spinal cord barrier in humans and rats","volume":"17","author":"Uchida","year":"2020","journal-title":"Mol. Pharm."},{"key":"B62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s0888-7543(03)00214-3","article-title":"Structural diversity and functional implications of the eukaryotic TDP gene family","volume":"83","author":"Wang","year":"2004","journal-title":"Genomics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1007\/s12035-022-02869-5","article-title":"Effect of TDP43-CTFs35 on brain endothelial cell functions in cerebral ischemic injury","volume":"59","author":"Xu","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12974-020-01952-9","article-title":"TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model","volume":"17","author":"Zamudio","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B66","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1172\/JCI76431","article-title":"Canonical WNT signaling components in vascular development and barrier formation","volume":"124","author":"Zhou","year":"2014","journal-title":"J. Clin. Invest."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1357204\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:35:56Z","timestamp":1723696556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1357204\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":67,"alternative-id":["10.3389\/fcell.2024.1357204"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2024.1357204","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"1357204"}}